Shares of Accolade, Inc. (NASDAQ:ACCD) have received a consensus rating of “Buy” from the thirteen analysts that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $43.73.
A number of brokerages recently commented on ACCD. Needham & Company LLC dropped their price objective on shares of Accolade from $56.00 to $33.00 and set a “buy” rating on the stock in a report on Tuesday, January 11th. Morgan Stanley dropped their price objective on shares of Accolade from $31.00 to $30.00 and set an “overweight” rating on the stock in a report on Tuesday, January 11th. SVB Leerink dropped their price objective on shares of Accolade from $58.00 to $52.00 and set an “outperform” rating on the stock in a report on Friday, October 8th. lowered their price target on shares of Accolade from $62.00 to $52.00 and set a “buy” rating on the stock in a research note on Friday, October 8th. Finally, Berenberg Bank reiterated a “buy” rating and issued a $61.00 price target on shares of Accolade in a research note on Friday, October 8th.
Institutional investors and hedge funds have recently made changes to their positions in the company. First Horizon Advisors Inc. bought a new position in shares of Accolade in the 3rd quarter valued at about $28,000. Strs Ohio bought a new position in shares of Accolade in the 3rd quarter valued at about $63,000. Great West Life Assurance Co. Can grew its position in shares of Accolade by 91.6% in the 2nd quarter. Great West Life Assurance Co. Can now owns 1,767 shares of the company’s stock valued at $96,000 after acquiring an additional 845 shares during the period. Walleye Capital LLC bought a new position in shares of Accolade in the 2nd quarter valued at about $217,000. Finally, Teacher Retirement System of Texas grew its position in shares of Accolade by 27.1% in the 3rd quarter. Teacher Retirement System of Texas now owns 5,187 shares of the company’s stock valued at $219,000 after acquiring an additional 1,106 shares during the period. 72.11% of the stock is owned by institutional investors.
Shares of NASDAQ ACCD opened at $15.89 on Friday. Accolade has a twelve month low of $15.73 and a twelve month high of $56.72. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.36. The company’s fifty day moving average is $23.75 and its 200-day moving average is $36.61. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of -9.18 and a beta of 1.82.
Accolade (NASDAQ:ACCD) last issued its quarterly earnings data on Monday, January 10th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of ($0.68) by $0.99. Accolade had a negative net margin of 33.86% and a negative return on equity of 20.66%. The business had revenue of $83.45 million for the quarter, compared to analyst estimates of $75.89 million. During the same period last year, the business posted ($0.32) earnings per share. The firm’s quarterly revenue was up 117.1% on a year-over-year basis. On average, research analysts anticipate that Accolade will post -1.87 EPS for the current fiscal year.
About Accolade
Accolade, Inc develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.